Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the trade name of Merck & Co., Inc., Rahway… read more
Turbine announced that Ono Pharmaceutical Co., Ltd. (Osaka, Japan, “Ono”) has selected multiple targets identified using Turbine’s in silico Simulated Cell™ platform for further development.… read more
Turbine announced that Ono Pharmaceutical Co., Ltd. (Osaka, Japan, “Ono”) has selected multiple targets identified using Turbine’s in silico Simulated Cell™ platform for further development.… read more
AI promises to create medicines faster, more cheaply, and with greater precision. Despite attracting big sums and splashy headlines, AI-powered biotechs have yet to get… read more
In this episode, we dive into the revolutionary work at Turbine Simulated Cell Technologies, where the intersection of artificial intelligence and biology is paving the… read more
Turbine announced that Ono Pharmaceutical Co., Ltd. (Osaka, Japan, “Ono”) has selected multiple targets identified using Turbine’s in silico Simulated Cell™ platform for further development.… read more